These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3591312)

  • 21. Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter.
    Ge B; Bodeis S; Walker RD; White DG; Zhao S; McDermott PF; Meng J
    J Antimicrob Chemother; 2002 Oct; 50(4):487-94. PubMed ID: 12356792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
    Domenico P; O'Leary R; Cunha BA
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):170-5. PubMed ID: 1396732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
    Simor AE; Ferro S; Low DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):108-9. PubMed ID: 2712542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
    J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility profiles of thermophilic campylobacters isolated from patients in the town of Nis.
    Miljković-Selimović B; Babić T; Kocić B; Ristić L
    Vojnosanit Pregl; 2009 Jul; 66(7):522-6. PubMed ID: 19678575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.
    McNulty CA; Dent JC
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):566-9. PubMed ID: 3141174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli.
    Gaudreau C; Gilbert H
    J Antimicrob Chemother; 1997 Jun; 39(6):707-12. PubMed ID: 9222038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium.
    Vandenberg O; Houf K; Douat N; Vlaes L; Retore P; Butzler JP; Dediste A
    J Antimicrob Chemother; 2006 May; 57(5):908-13. PubMed ID: 16533825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
    Vega-Jiménez AL; Almaguer-Flores A; Flores-Castañeda M; Camps E; Uribe-Ramírez M; Aztatzi-Aguilar OG; De Vizcaya-Ruiz A
    Nanotechnology; 2017 Oct; 28(43):435101. PubMed ID: 28837052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
    Thwaites RT; Frost JA
    J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility of Campylobacter pyloridis to antibiotics].
    Freland C; Massoubre B; Drugeon HB
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):809-12. PubMed ID: 3309819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.
    Tremblay C; Gaudreau C
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1847-9. PubMed ID: 9661033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bismuth subcarbonate against Campylobacter pylori: do citrate ions improve antibacterial activity?
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1990 May; 273(1):33-5. PubMed ID: 2363796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
    Lariviere LA; Gaudreau CL; Turgeon FF
    J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
    Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals.
    Randall LP; Ridley AM; Cooles SW; Sharma M; Sayers AR; Pumbwe L; Newell DG; Piddock LJ; Woodward MJ
    J Antimicrob Chemother; 2003 Sep; 52(3):507-10. PubMed ID: 12917241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.
    Lambert T; Mégraud F; Gerbaud G; Courvalin P
    Antimicrob Agents Chemother; 1986 Sep; 30(3):510-1. PubMed ID: 3777915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucralfate, bismuth subcitrate, and gastric HCO3 in humans.
    Guslandi M
    Gut; 1990 Aug; 31(8):958-9. PubMed ID: 2387525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.